| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |